A consortium of 12 European partners have been awarded €6million by the European Commission for a research and development project focused on directing stem cells to become bone and muscle.
Pluripotent stem cells have the potential to generate any type of cell found in the body. They are generated and multiplied in the laboratory. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
The project combines the expertise of ten academic and two industrial partners to bring together stem cell experts, genetic engineers, developmental biologists, cell therapy pioneers, bioengineers and specialist SMEs in a cross-disciplinary collaborative effort. PluriMes is supported through the European Commission’s Framework 7 HEALTH research programme and Coordinated by Professor Austin Smith from the Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute at the University of Cambridge.
For useful information, FAQs, news and films on stem cells in general, visit EuroStemCell, an accessible European Stem Cell Portal.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement No .